Pyroxene Biotechnology is engaged in the development, manufacturing, and marketing of in vitro immunodiagnostic and genetic-diagnostic reagents for cancer, hepatic fibrosis, myocardial infarction, rheumatism and rheumatoid. The company's product or service portfolio includes Genetic analysis (Gene testing, gene extraction, virus packing, and RNA interference); Preparation and analysis of polypeptides and proteins (Peptide synthesis, protein expression and purification, protein analysis); Antibody preparation and immune-analysis (Customized antibody, immunodiagnostic reagents for rheumatism and rheumatoid and related services); Immunodiagnostic kit with multiple proteins for multiple cancers and Biopsy and dissection devices for cancerous mass.